| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.08 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.08 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | -0.052 | 0.08 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | -0.059 | 0.08 |
| mRNA | ABT-263 | FIMM | pan-cancer | AAC | -0.25 | 0.08 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.066 | 0.08 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | -0.052 | 0.08 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.066 | 0.09 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | -0.088 | 0.09 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | -0.28 | 0.09 |